MTNB Matinas BioPharma Holdings, Inc.

$0.18 -4.62%

Updated 16 d ago

Healthcare · Pharmaceutical Preparations

Matinas BioPharma Holdings, Inc. (MTNB) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $3 million. Shares last traded at $0.18, 94.2% below their 52-week high. Over the past year the stock is down 88.8%. Net profit margin is -610.5%, below the peer median of -8.9%. Revenue declined 65.6% year over year.

Market Cap

$3M

Shares Out

14.7M

EPS (TTM)

$-3.91

P/E Ratio

—

P/S Ratio

2.41

P/B Ratio

1.47

Dividend / Share

—

Dividend Yield

—

52-Week High

$3.08

52-Week Low

$0.18

Volume

12,636

Avg Vol (3m)

70,982.444

Performance

-9.39%

-34.20%

-76.38%

-70.81%

YTD

-70.08%

-88.78%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. MTNB split history →

Technicals

RSI (14)

32.49

SMA (50)

$0.35

SMA (200)

$0.64

Price vs SMA50

-48.40%

Price vs SMA200

-72.10%

ATR (14)

$0.03

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$1M

Net Income

$-7M

Gross Margin

—

Operating Margin

-608.4%

Net Margin

-610.5%

Return on Equity

-371.7%

Return on Assets

-196.1%

Current Ratio

0.85

Debt / Equity

0.90

Revenue Growth (YoY)

-65.6%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.51	2026-08-13
Q1 2026	$-0.30	2026-05-08
FY 2025	$-2.00	2026-03-31
Q3 2025	$-1.74	2025-11-10
Q2 2026	$-1.36	2026-08-13
Q1 2026	$-0.33	2026-05-08

Full earnings history →

Pharmaceutical Preparations peers

MTNB vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 16 d ago

P/S vs peers

2.41 / 11.11 med

-78% discount

Net margin vs peers

-610.5% / -8.9% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.